The last 12 months have been a bit boring for Novartis AG (NYSE:NVS) and have resulted in a lack of my coverage updates on the company. The stock has delivered a total return of around 18% since my ...

Jamie Dimon is right to be alarmed about our national-security vulnerabilities, especially an overreliance on China and India for generic prescription drugs (“Investments for National Security,” op-ed ...

Faced with the prospect of tariffs on imported medicines threatened by the Trump administration, Indian drugmaker Hikma has said it will spend $1 billion to expand its manufacturing and R&D operations ...

NovartisNVS stock undercut the lower boundary of its chase zone Tuesday after generics took a big bite out of Entresto, the heart-failure drug that accounts for 13% of the Swiss company's sales.

FDA Commissioner Dr. Marty Makary joins 'Squawk Box' to discuss plans to speed up the approval of biosimilar generic drugs in a plan to help lower health care costs, pushback from the pharmaceuticals ...

Before government shutdowns end, political blame games begin. And as politicians from both parties try to blame each other, party operatives and pundits scour the poll data to see who wins the game.

Unveiling a suite of new products at ClioCon, the annual conference hosted by British Columbia-based legal tech company Clio, company chief executive officer and founder Jack Newton argued unreliable ...

The Rasmussen Reports daily Presidential Tracking Poll for Tuesday shows that 45% of Likely U.S. Voters approve of President Trump’s job performance. Fifty-three (53%) disapprove. The latest figures ...

After Netflix bought the Roald Dahl Story Company in 2021, it seemed like the next logical step was for the streamer to milk every last drop of nostalgia from its new cash cow, leaving it a desiccated ...

Danish vaccine developer Evaxion has released long-term data for its lead personalized cancer vaccine, with the shot scoring a 75% objective response rate (ORR) in patients with advanced melanoma ...